Quest Diagnostics DGX
NYSE DGX
$247.35 +0.27 (+0.11%)
As of: Sep 17, 2026 · 3:59 PM EDT

Quest Diagnostics (DGX) EBIT Margin Growth (3y) (2012 - 2026)

Analysis

Quest Diagnostics (DGX) EBIT Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (3y) (Qtr)
1 Natera 49.39 Bn 48.29 Bn 486.15 Mn 3,294.00
2 Quest Diagnostics 27.49 Bn 26.86 Bn 1.03 Bn 20.00
3 Labcorp Holdings 26.51 Bn 26.37 Bn 1.11 Bn 333.00
4 Guardant Health 23.17 Bn 22.12 Bn 219.03 Mn 4,867.00
5 Tempus AI 12.59 Bn 11.77 Bn 274.25 Mn 1,424.00
6 Caris Life Sciences 8.01 Bn 7.22 Bn 182.38 Mn -
7 Sotera Health 5.53 Bn 5.17 Bn 177.96 Mn 941.00
8 BillionToOne 4.80 Bn 4.25 Bn 77.11 Mn -
9 Adaptive Biotechnologies 4.40 Bn 4.05 Bn 51.39 Mn 7,570.00
10 iRhythm Holdings 3.68 Bn 3.08 Bn 163.21 Mn 1,407.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.00
Mar 31, 2026 70.00
Dec 31, 2025 797.00
Sep 30, 2025 -206.00
Jun 30, 2025 5.00
Mar 31, 2025 -660.00
Dec 31, 2024 -576.00
Sep 30, 2024 -1,024.00
Jun 30, 2024 -609.00
Mar 31, 2024 -1,159.00
Dec 31, 2023 -1,481.00
Sep 30, 2023 -1,087.00
Jun 30, 2023 -61.00
Mar 31, 2023 348.00
Dec 31, 2022 -1,306.00
Sep 30, 2022 -23.00
Jun 30, 2022 10.00
Mar 31, 2022 653.00
Dec 31, 2021 757.00
Sep 30, 2021 741.00